刺客信条

China approves first-ever drug for acute mountain sickness prevention_我的网站

荡寇风云

A |

　阿里云优惠券先领券再下单 2025年618淘宝京东淘宝红包活动最后一波领取结束时间是2025年6月18日23:59:59，最后使用时间截止6月20日23:59:59。

B |

Medicine File photo: VCG
China has granted marketing approval of its first drug for the prevention of acute mountain sickness, filling the long-standing gap in the domestic market where no such medications had been available, Science and Technology Daily reported on Tuesday.
The National Medical Products Administration (NMPA) has approved the marketing of acetazolamide sustained-release capsules, the report said. As the first specialized drug in China indicated for preventing of acute mountain sickness, its approval marks the end of the country's lack of dedicated preventive treatment for altitude illness.
By inhibiting the activity of carbonic anhydrase, acetazolamide promotes the renal excretion of bicarbonate, corrects respiratory alkalosis caused by hypoxia at high altitudes, thereby regulating acid-base balance, optimizing respiratory status, elevating blood oxygen levels, and reducing the risk of onset at the source.
In contrast to health products that only provide auxiliary regulatory effects, this medication has been validated through stringent clinical trials and stands as a specialized drug approved by the NMPA with a clear indication for prevention, said the report.
Led by principal investigator is Luobu Gesang, a deputy dean of the People's Hospital of Xizang Autonomous Region, the clinical trial was designed by his team and has yielded critical evidence to inform prevention strategies for altitude sickness that are specifically adapted to Chinese and Asian populations.
"Previously, although acetazolamide had already been used internationally for the prevention of acute mountain sickness, China had long lacked an NMPA-approved acetazolamide formulation supported by rigorous clinical trials. Furthermore, the existing international formulations were short-acting tablets requiring multiple daily doses, and no drugs with the relevant indication were available on the domestic market for an extended period," said Luobu Gesang.
The sustained-release capsule approved this time not only fills this critical gap but also optimizes the dosage form, providing more reliable and convenient medication protection for the physical health and life safety of people entering high-altitude areas, he added.
Clinical trials showed that, compared with the placebo group, the incidence of acute mountain sickness in the medication group was significantly reduced, with the incidence of moderate-to-severe acute mountain sickness decreasing by 14.6 percent, according to the report.
Related research has been published in the international flagship journal of high-altitude medicine, High Altitude Medicine & Biology.
Global Times
。请在2025年618红包领取活动结束前，每天都可以领取一次，在618红包失效前使用可享受优惠。 一、淘宝天猫618 淘宝天猫618最后一波红包领取时间是：2025年6月11日 ~ 6月18日 23:59:59 淘宝天猫618最后一波红包领取口令是：好运红包7700 淘宝天猫618最后一波红包口令使用方法是：在2025年淘宝天猫618红包领取活动时间内，每天都可以打开手机淘宝或天猫APP，搜索框内输入红包领取口令【 好运红包7700 】，搜索进入2025年淘宝天猫618官方活动红包领取入口，就有机会得最高25888元超级红包，叠加618官方立减、补贴券、88VIP会员、优惠券等优惠力度会更大。

淘宝京东天猫2025年618红包领取口令是什么？618淘宝京东天猫红包活动最后一波结束时间是什么时候？每天都可以通过红包口令领取一次，下次领取只需要再次打开手机淘宝或天猫APP，点击搜索框，找到历史搜索记录里的红包领取口令【 好运红包7700 】，搜索进入2025年淘宝天猫618官方活动红包领取入口，就有机会得最高25888元超级红包，叠加618官方立减、补贴券、88VIP会员、优惠券等优惠力度会更大。淘宝京东天猫2025年618红包领取口令是什么？618淘宝京东天猫红包活动最后一波结束时间是什么时候？ 二、京东618 京东618最后一波红包领取时间是：2025年6月11日 ~ 6月18日 23:59:59 京东618最后一波红包领取口令是：红包到手755 京东618最后一波红包口令使用方法是：在2025年京东618红包领取活动时间内，每天都可以打开手机京东APP，搜索框内输入红包领取口令【 红包到手755 】，搜索进入2025年京东618官方活动红包领取入口，就有机会得最高25618元京享红包，叠加618跨店满减、官方立减、补贴券、Plus会员、优惠券等优惠力度会更大。淘宝京东天猫2025年618红包领取口令是什么？618淘宝京东天猫红包活动最后一波结束时间是什么时候？每天都可以通过红包口令领取一次，下次领取只需要再次打开手机京东APP，点击搜索框，找到历史搜索记录里的红包领取口令【红包到手755 】，搜索进入2025年京东618官方活动红包领取入口，就有机会得最高25618元京享红包，叠加618跨店满减、官方立减、补贴券、Plus会员、优惠券等优惠力度会更大。淘宝京东天猫2025年618红包领取口令是什么？618淘宝京东天猫红包活动最后一波结束时间是什么时候？ 三、618优惠券 打开词令APP，输入口令“ aa66 ”，搜索直达该口令关联的目标领取淘宝天猫、京东内部隐藏优惠券，享券后价优惠。